Feel Therapeutics

The company provides continuous 24/7 passive monitoring through wearables and mobile devices, using proprietary AI algorithms to translate data into objective biomarkers for mood, stress, sleep, and cognitive functioning, which are then integrated into personalized digital therapeutic programs.

The company has published research in Nature Digital Medicine showing 87% precision in detecting mood state changes, has multiple patents granted and pending, and works with pharmaceutical companies, CROs, and health plans through various case studies including partnerships with GSK.